{"id":"https://openalex.org/W2039188597","doi":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","title":"Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumors","display_name":"Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumors","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2039188597","doi":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","mag":"2039188597","pmid":"https://pubmed.ncbi.nlm.nih.gov/11241251"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","doi":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2820010215%2991%3A4%3C815%3A%3AAID-CNCR1069%3E3.0.CO%3B2-J","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2820010215%2991%3A4%3C815%3A%3AAID-CNCR1069%3E3.0.CO%3B2-J","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074338449","display_name":"Peter S. Kozuch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Kozuch","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072207853","display_name":"Paulo M. Hoff","orcid":"https://orcid.org/0000-0002-0065-2194","observed_orcids":["https://orcid.org/0000-0002-0065-2194"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paulo M. Hoff","raw_affiliation_strings":["","Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas","Fax: (713) 745-1163"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Fax: (713) 745-1163","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005194857","display_name":"Kenneth R. Hess","orcid":"https://orcid.org/0000-0003-1377-6070","observed_orcids":["https://orcid.org/0000-0003-1377-6070"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Hess","raw_affiliation_strings":["Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Adams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Adams","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083929738","display_name":"Robert Alan Newman","orcid":"https://orcid.org/0000-0001-5661-5846","observed_orcids":["https://orcid.org/0000-0001-5661-5846"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Newman","raw_affiliation_strings":["Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Francis Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francis Lee","raw_affiliation_strings":["SuperGen Pharmaceuticals, San Ramon, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SuperGen Pharmaceuticals, San Ramon, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051520990","display_name":"Richard Pazdur","orcid":"https://orcid.org/0000-0002-4771-9923","observed_orcids":["https://orcid.org/0000-0002-4771-9923"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Pazdur","raw_affiliation_strings":["Division of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5072207853"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.10726494,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"91","issue":"4","first_page":"815","last_page":"821"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6503999829292297,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6503999829292297,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.08150000125169754,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.054999999701976776,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitomycin-c","display_name":"mitomycin C","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8809999823570251},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.8999999761581421},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.7039999961853027},{"id":"https://openalex.org/keywords/infusion-related-toxicity","display_name":"infusion-related toxicity","score":0.765999972820282},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7730000019073486},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8472819328308105},{"id":"https://openalex.org/C2779338040","wikidata":"https://www.wikidata.org/wiki/Q19856779","display_name":"Mitomycin C","level":2,"score":0.6284659504890442},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.5033006072044373},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3805786371231079},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3509221374988556},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2736126780509949},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.217489093542099}],"mesh":[{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016685","descriptor_name":"Mitomycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016685","descriptor_name":"Mitomycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016685","descriptor_name":"Mitomycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","doi":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2820010215%2991%3A4%3C815%3A%3AAID-CNCR1069%3E3.0.CO%3B2-J","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"doi:10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.3.co;2-a","doi":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.3.co;2-a","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.3.co;2-a","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:11241251","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11241251","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","doi":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(20010215)91:4<815::aid-cncr1069>3.0.co;2-j","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2820010215%2991%3A4%3C815%3A%3AAID-CNCR1069%3E3.0.CO%3B2-J","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2039188597.pdf","grobid_xml":"https://content.openalex.org/works/W2039188597.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W152943885","https://openalex.org/W1551324820","https://openalex.org/W1591975370","https://openalex.org/W1598919268","https://openalex.org/W1935541780","https://openalex.org/W1964031998","https://openalex.org/W1967538839","https://openalex.org/W1976437471","https://openalex.org/W1990737033","https://openalex.org/W2013273719","https://openalex.org/W2020337784","https://openalex.org/W2025142143","https://openalex.org/W2028714807","https://openalex.org/W2059015520","https://openalex.org/W2071757804","https://openalex.org/W2084067926","https://openalex.org/W2103164714","https://openalex.org/W2126077921","https://openalex.org/W2129790776","https://openalex.org/W2148065767","https://openalex.org/W2171407157","https://openalex.org/W2325499173","https://openalex.org/W2326287562","https://openalex.org/W2463030429","https://openalex.org/W4296978003"],"related_works":["https://openalex.org/W1591975370","https://openalex.org/W7009088378","https://openalex.org/W2401902302","https://openalex.org/W2021313022","https://openalex.org/W2383187162","https://openalex.org/W2039553930","https://openalex.org/W300286224","https://openalex.org/W6986798382","https://openalex.org/W2052473497","https://openalex.org/W2380178304"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1,138],"study":[2,36],"compares":[3],"serum":[4,114],"pharmacokinetics,":[5],"urinary":[6],"excretion":[7],"patterns,":[8],"and":[9,22,48,83,115,125,198,218,229,254],"relative":[10],"bioequivalencies":[11],"of":[12,15,46,105,132,148,162,185,227,234,256],"single":[13,53],"doses":[14,55],"MitoExtra":[16],"(ME;":[17],"SuperGen,":[18],"San":[19],"Ramon,":[20],"CA)":[21],"mitomycin":[23],"C":[24],"(MMC).":[25],"METHODS:":[26],"Thirty-five":[27],"patients":[28,92,120,171,180],"were":[29,62,78,98,156,201,208],"entered":[30],"into":[31],"this":[32,257],"open-label,":[33],"single-institution,":[34],"crossover":[35,189],"with":[37,93,215,221],"2":[38],"treatment":[39,74],"arms.":[40],"Each":[41],"patient":[42],"received":[43,122],"alternating":[44],"courses":[45,77,104],"ME":[47,68,124,192,230,243],"MMC":[49,70,126,216,228,235],"as":[50,71],"15":[51],"mg/m(2)":[52],"intravenous":[54,59],"via":[56],"a":[57],"short":[58],"infusion.":[60],"Patients":[61],"sequentially":[63],"assigned":[64],"to":[65,88,195,249],"receive":[66],"either":[67],"or":[69],"their":[72],"first":[73,102],"course.":[75],"The":[76,108,173,224],"given":[79],"in":[80,91,160,169,241],"6-week":[81],"intervals":[82],"could":[84],"be":[85],"repeated":[86],"up":[87],"4":[89],"times":[90],"responding":[94],"disease.":[95],"Pharmacokinetic":[96],"parameters":[97,152,165],"analyzed":[99],"during":[100],"the":[101,129,142,149,163,178,186,204,237,242,251],"two":[103,134,205],"therapy.":[106],"RESULTS:":[107],"noncompartmental":[109],"pharmacokinetic":[110,151,188],"analysis":[111],"conducted":[112,176],"on":[113,177],"urine":[116],"data":[117],"obtained":[118,166],"from":[119,236],"who":[121],"both":[123,183],"indicates":[127],"that":[128,181,191],"kinetic":[130,164],"disposition":[131],"these":[133],"formulations":[135],"is":[136,139,193],"similar.":[137],"evident":[140],"when":[141],"mean":[143],"(+/-":[144],"standard":[145],"deviation)":[146],"values":[147],"various":[150],"are":[153,247],"compared.":[154],"There":[155,207],"no":[157],"significant":[158,211],"differences":[159],"any":[161],"between":[167,203],"treatments":[168],"all":[170],"examined.":[172],"statistical":[174],"evaluation":[175],"25":[179],"completed":[182],"arms":[184],"2-way":[187],"demonstrates":[190],"bioequivalent":[194],"MMC.":[196],"Hematologic":[197],"nonhematologic":[199],"toxicities":[200],"similar":[202,225],"treatments.":[206],"three":[209],"clinically":[210],"infusion-related":[212],"complications":[213],"associated":[214,220],"administration":[217],"none":[219],"ME.":[222],"CONCLUSIONS:":[223],"pharmacokinetics":[226],"suggest":[231],"complete":[232],"release":[233],"hydroxypropyl-Beta-cyclodextrin":[238],"carrier":[239],"contained":[240],"formulation.":[244],"Further":[245],"studies":[246],"needed":[248],"define":[250],"pharmacodynamics,":[252],"toxicity,":[253],"efficacy":[255],"drug-carrier":[258],"complex.":[259]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}